You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Ascending dose‐controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women
|
---|---|
Published in |
Obesity, May 2013
|
DOI | 10.1002/oby.20356 |
Pubmed ID | |
Authors |
T. E. Hughes, D. D. Kim, J. Marjason, J. Proietto, J. P. Whitehead, J. E. Vath |
Abstract |
Evaluate the safety and tolerability of beloranib, a fumagillin-class methionine aminopetidase-2 (MetAP2) inhibitor, in obese women over 4 weeks. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 20% |
Unknown | 4 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 103 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 16 | 16% |
Researcher | 14 | 14% |
Student > Bachelor | 14 | 14% |
Student > Master | 12 | 12% |
Student > Doctoral Student | 7 | 7% |
Other | 17 | 17% |
Unknown | 23 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 36 | 35% |
Agricultural and Biological Sciences | 8 | 8% |
Biochemistry, Genetics and Molecular Biology | 6 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
Nursing and Health Professions | 5 | 5% |
Other | 17 | 17% |
Unknown | 25 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 January 2019.
All research outputs
#1,404,459
of 24,571,708 outputs
Outputs from Obesity
#848
of 4,233 outputs
Outputs of similar age
#11,315
of 198,951 outputs
Outputs of similar age from Obesity
#43
of 211 outputs
Altmetric has tracked 24,571,708 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,233 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 37.6. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,951 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 211 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.